Received Mar 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
felt weak; had a slight fever for two days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On 26-FEB-2026, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: had a slight fever for two days). On an unknown date, the patient experienced feelings of weakness (Verbatim: felt weak). The outcome of the fever and feelings of weakness were not reported. It was unknown if the reporter considered the fever and feelings of weakness to be related to Shingles vaccine. It was unknown if the company considered the fever and feelings of weakness to be related to Shingles vaccine. Additional Information: GSK receipt date: 27-FEB-2026 The patient received the first dose and after that patient had a slight fever for two days and felt weak. The patient mentioned that he will be taking the second dose in next month. The batch number was not provided, and we are unable to contact the reporter.